Feature | November 02, 2012

Elekta, Philips Research to Create MRI-Guided Radiation Therapy

New system would merge MRI and a linear accelerator together in one system

November 2, 2012 — Elekta and Philips announced they will expand a joint program to develop an imaging treatment platform that merges radiation therapy and magnetic resonance imaging (MRI) technology in a single treatment system. The program for development will include a research consortium of leading radiation oncology centers and clinicians, including the University Medical Center Utrecht (the Netherlands).

The establishment of the consortium marks the next step in the collaboration between Elekta and Philips. The consortium's mission will be to merge precision radiation delivery with MRI in a single MRI-guided radiation therapy system. This will enable doctors to achieve exceptional soft tissue imaging during radiation therapy and to adapt treatment delivery in real-time for extremely precise cancer treatments.

"Bringing the superior soft tissue imaging of MRI and precise radiotherapy together in one device could potentially revolutionize cancer care," says Tomas Puusepp, president and CEO of Elekta. "The need to maximize therapeutic radiation on the target, while minimizing the exposure of healthy tissue, is entirely driven by the best interests of the patient — they deserve the best chance for a cure and an improved quality of life. Elekta and Philips are leaders in the global healthcare community with a complete spectrum of expertise to fulfill this vision."

"Cancer is a major global disease that we hope to control with more targeted treatments," says Gene Saragnese, CEO Imaging Systems at Philips Healthcare. "MRI is emerging in oncology applications because of its excellent real-time 3-D visualization of soft tissue. Together with our partners, all leaders in radiation therapy delivery, we are convinced that the integrated MRI-guided radiation therapy system has the potential to become a game changer in cancer care on a global scale."

Working with University Medical Center Utrecht, the companies have built and tested a prototype system that integrates a linear accelerator and a 1.5T MRI system. The success of early tests has enabled the project to move to the next phase of development and testing by a select group of consortium partners.

"We are proud and excited about this project," adds Jan Lagendijk, department of radiotherapy, University Medical Center Utrecht. "Elekta, Philips and my department have strived for over a decade to make this possible. Through real-time imaging of both tumors and organs at risk, an integrated MRI-guided radiation therapy system would enable us to see more precisely than ever what we treat, and irradiate just the tumor as it moves in the body during treatment. This could potentially bring significant benefits to patients and overall healthcare economics."

Radiotherapy is one of the primary modalities used to treat cancer, either as a standalone treatment or used with other modalities such as chemotherapy. The technique involves identifying cancerous tissue and irradiating it with high energy radiation beams in a way that maximizes sparing of healthy tissue near the tumor. Radiation therapy delivered by linear accelerators and medical imaging already play an essential role in treatment planning, delivery and after care, and is a proven cost-effective and safe method for treating patients with cancer.

For more information: www.elekta.com, www.philips.com/newscenter

Related Content

Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Reduced hippocampal volume on MRI

This figure shows reduced hippocampal volume over the course of 6 years as seen on progressive volumetric analysis and also coronal MRI evaluations (arrows).Progressive volume loss in the mesial temporal lobe on MRI is a characteristic imaging feature of AD. This patient was a case of Alzheimer’s Dementia.

 

News | Neuro Imaging | June 12, 2018
According to a UCLA Medical Center study, a new technology shows the potential to help doctors better determine when...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Philips Receives FDA 510(k) for Ingenia Elition MR System
Technology | Magnetic Resonance Imaging (MRI) | June 07, 2018
Philips announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its...
Overlay Init